The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration

被引:203
作者
Petrie, Timothy A. [1 ,2 ]
Raynor, Jenny E. [3 ]
Reyes, Catherine D. [1 ,2 ]
Burns, Kellie L. [1 ,2 ]
Collard, David M. [3 ]
Garcia, Andres J. [1 ,2 ]
机构
[1] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA
[3] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA
关键词
bone; fibronectin; cell adhesion; RGD; FAK; integrins;
D O I
10.1016/j.biomaterials.2008.03.036
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Implant osseointegration, defined as bone apposition and functional fixation, is a requisite for clinical success in orthopaedic and dental applications, many of which are restricted by implant loosening. Modification of implants to present bioactive motifs such as the RGD cell-adhesive sequence from fibronectin (FN) represents a promising approach in regenerative medicine. However, these biomimetic strategies have yielded only marginal enhancements in tissue healing in vivo. In this study, clinical-grade titanium implants were grafted with a non-fouling oligo(ethylene glycol)-substituted polymer coating functionalized with controlled densities of ligands of varying specificity for target integrin receptors. Biomaterials presenting the alpha(5)beta(1)-integrin-specific FN fragment FNIII7-10 enhanced osteoblastic differentiation in bone marrow stromal cells compared to unmodified titanium and RGD-presenting surfaces. Importantly, FNIII7-10-functionalized titanium significantly improved functional implant osseointegration compared to RGD-functionalized and unmodified titanium in vivo. This study demonstrates that bioactive coatings that promote integrin binding specificity regulate marrow-derived progenitor osteoblastic differentiation and enhance healing responses and functional integration of biomedical implants. This work identifies an innovative strategy for the rational design of biomaterials for regenerative medicine. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2849 / 2857
页数:9
相关论文
共 36 条
[1]
*AM AC ORTH SURG, 2003, ARTHR TOT JOINT REPL
[2]
Biological responses to materials [J].
Anderson, JM .
ANNUAL REVIEW OF MATERIALS RESEARCH, 2001, 31 :81-110
[3]
[Anonymous], 1999, NAT ARTHR ACT PLAN P
[4]
Peri-implant bone formation and implant integration strength of peptide-modified p(AAm-co-EG/AAc) interpenetrating polymer network-coated titanium implants [J].
Barber, Thomas A. ;
Ho, James E. ;
De Ranieri, Aladino ;
Virdi, Amarjit S. ;
Sumner, Dale R. ;
Healy, Kevin E. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2007, 80A (02) :306-320
[5]
The pathology of total joint arthroplasty - II. Mechanisms of implant failure [J].
Bauer, TW ;
Schils, J .
SKELETAL RADIOLOGY, 1999, 28 (09) :483-497
[6]
The pathology of total joint arthroplasty I. Mechanisms of implant fixation [J].
Bauer, TW ;
Schils, J .
SKELETAL RADIOLOGY, 1999, 28 (08) :423-432
[7]
Peptidomimetic antagonists of αvβ3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone [J].
Carron, CP ;
Meyer, DM ;
Engleman, VW ;
Rico, JG ;
Ruminski, PG ;
Ornberg, RL ;
Westlin, WF ;
Nickols, GA .
JOURNAL OF ENDOCRINOLOGY, 2000, 165 (03) :587-598
[8]
Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO
[9]
2-6
[10]
In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene [J].
Cheng, SL ;
Lou, J ;
Wright, NM ;
Lai, CF ;
Avioli, LV ;
Riew, KD .
CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (02) :87-94